Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of...
Dr Anne-Catherine POULEUR : Cardiologue - institut cardiovasculaire Saint Luc - Bruxelles BELGIQUE
Routine ambulatory heart rhythm monitoring for detection of atrial arrhythmias in transthyretin...
Dr Vincent ALGALARRONDO : Cardiologue APHP Bichat - Paris Routine ambulatory heart rhythm…
Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing...
Dr Silvia OGHINA : Cardiologue APHP Henri Mondor - Créteil Incidence and Characterization…
Prevalence and determinants of iron deficiency in cardiac amyloidosis.
Dr Benoît LEQUEUX : Cardiologue CHU de Poitiers Prevalence and determinants of iron…
Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey...
Pr François TOURNOUX : Cardiologue - CHU de Montréal CANADA Characteristics of patients…
Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression.
Dr Eve CARIOU - Cardiologue CHU de Toulouse Reduction in CMR Derived Extracellular…
Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy...
Dr Zoubida TAZI MEZALEK - Cardiologue CHU de Rabat MAROC Causes of Cardiovascular…
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in...
Dr Martin NICOL : Cardiologue APHP Lariboisière - Paris https://pubmed.ncbi.nlm.nih.gov/35292807/ PMID : 35292807
Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin...
Dr Clément BECLE Cardiologique - Centre Cardiologique de l'Ouest Lyonnais - Lyon https://pubmed.ncbi.nlm.nih.gov/33220323/…
ST‑elevation myocardial infarction among cardiac amyloidosis patients; a national readmission database study
Pr François ROUBILLE : Cardiologue resp. équipe médicale insuffisance cardiaque - CHU de…
Clinical features and predictors of atrial fibrillation in patients with light-chain or...
Dr Damien EYHARTS : Cardiologue CHU de Toulouse Clinical features and predictors of…
Utilization and tolerance of beta-blockers among patients with AL amyloidosis.
Jean-Jacques VON HUNOLSTEIN : Cardiologue Hopital Civil STRASBOURG Utilization and tolerance of beta-blockers…
Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels...
Antoine JOBBE-DUVAL : Cardiologue HCL LYON Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide…
Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy.
Patricia RÉANT : Cardiologue - CHU de BORDEAUX Long-Term Survival With Tafamidis in…
Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.
Emmanuelle BERTHELOT : adjointe chef de service, Cardiologue - APHP CHU Bicêtre Unveiling outcomes in…
Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis
Jean-Pierre GUEFFET : Cardiologue Hôpital Privé du Confluent - Nantes https://pubmed.ncbi.nlm.nih.gov/34734/
Mode of death and outcomes of implantable cardioverter defibrillators in transthyretin amyloid...
Frédéric MOUQUET : Cardiologue CHU de Lille https://pubmed.ncbi.nlm.nih.gov/34843821/
The role of serial (99m)Tc-DPD scintigraphy in monitoring cardiac transthyretin amyloidosis
Pierre TROISFONTAINES - Cardiologue CHR de la Citadelle Liège - BELGIQUE The role…
Spironolactone in Patients With an Echocardiographic HFpEF Phenotype Suggestive of Cardiac Amyloidosis:...
Erwan DONAL : cardiologue CHU de Rennes Spironolactone in Patients With an Echocardiographic…
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation.
Thibaut WAJCHERT - Dr Junior au CHU de Versailles Arterial thrombo-embolic events in…
Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosis
Damien EYHARTS - cardiologue CHU de Toulouse Impact of tricuspid regurgitation on survival…
Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence...
Anne-Catherine POULEUR - chef de clinique service de cardiologie - institut cardiovasculaire Saint…
Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic
François ROUBILLE - cardiologue resp. équipe médicale insuffisance cardiaque - CHU Montpellier Management…
Diuretic dose and NYHA functional class are independent predictors of mortality in...
Lise LEGRAND - Cardiologue APHP Pitié Salpêtrière PARIS Diuretic dose and NYHA functional…
Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis....
Frédéric MOUQUET - cardiologue LIlle Impact of afterload and infiltration on coexisting aortic…
Longitudinal strain is an independent predictor of survival and response to therapy...
Patricia REANT Longitudinal strain is an independent predictor of survival and response to…
Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis.
Damien GUIJARRO Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis. https://pubmed.ncbi.nlm.nih.gov/34419399/…
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of...
Olivier LAIREZ : Cardiologue CHU Rangueil - Toulouse Ventricular tachyarrhythmias and sudden cardiac…
Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms
Marc-Antoine DELBARRE - interniste CHU Henri MONODR Artificial intelligence-enabled fully automated detection of…
Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With...
Olivier HUTTIN Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients…
